Literature DB >> 2439351

Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.

C Walker, F Bettens, W J Pichler.   

Abstract

Binding of anti-CD3 antibody BMA030-F(ab')2 to T cells is not able to induce T cell proliferation even after additional cross-linking by plastic-bound goat anti-mouse Ig antibodies (panning) and addition of either interleukin (IL) 1 or IL2. In search for agents able to complement the signals provided by BMA030-F(ab')2, several antibodies directed against CD2, CD4, CD5, CD6 and CD8 were used. Neither of these caused T cell proliferation either by themselves or when simply added together with BMA030-F(ab')2. However, if BMA030-F(ab')2 and any other of these anti-CD2, CD4, CD5, CD6 or CD8 antibodies were cross-linked, then proliferation of T cells occurred. The mitogenic effect of cross-linking BMA030-F(ab')2 and a second anti-T cell antibody is dependent on the presence of monocytes or exogenously added IL2. The enhancing effect of monocytes could not be replaced by addition of IL1, suggesting that other soluble factors or monocyte contact might be involved in induction of activation signals. The mechanism leading to this mitogenic effect is dependent on combining cross-linking of BMA030 with the second anti-T cell antibody, whereby the second antibody appears to act as an "anchor" for the CD3 antibody, controlling and/or changing the signal transduction via the CD3 structure. This "anchor" hypothesis could be substantiated by the following observations: the best stimulatory signals were obtained at a BMA030/anti-T cell antibody ratio of 1:1; the effect is independent of the antibody isotype and the epitope recognized by the second antibody; the binding of BMA030 and separate cross-linking of the anti-T cell antibody was not sufficient to trigger T cell mitogenesis; immobilization by direct binding of the CD3 antibody alone or of the CD3 and second membrane structure/antibody complex separately was not sufficient to stimulate T cell proliferation. A further interesting aspect of this finding is the fact that a selective T cell stimulation is possible, since cross-linking BMA030-F(ab')2 plus anti-CD4 antibodies induced a selective stimulation of T4 cells, while cross-linking BMA030-F(ab')2 plus anti-CD8 activated solely T8 cells. It is thus possible to selectively activate T cell subsets in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439351     DOI: 10.1002/eji.1830170622

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Molecular linkage of the mouse CD5 and CD6 genes.

Authors:  O Lecomte; J B Bock; B W Birren; D Vollrath; J R Parnes
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  Coaggregation of the T-cell receptor with CD4 and other T-cell surface molecules enhances T-cell activation.

Authors:  T Owens; B Fazekas de St Groth; J F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Activation of human T lymphocytes: differential effects of CD3- and CD8-mediated signals.

Authors:  Y Samstag; F Emmrich; T Staehelin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Familial primary gastric lymphoma.

Authors:  D Hayoz; M Extermann; B F Odermatt; P Pugin; C Regamey; H Knecht
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

Review 5.  Contributions of the adaptive immune system to mood regulation: Mechanisms and pathways of neuroimmune interactions.

Authors:  Miles Herkenham; Stacey L Kigar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-09-06       Impact factor: 5.067

6.  Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants.

Authors:  T D Geppert; P E Lipsky
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

7.  Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.

Authors:  J Verwilghen; M L Baroja; F Van Vaeck; J Van Damme; J L Ceuppens
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

8.  The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.

Authors:  Simin D Rezaei; Hao K Lu; J Judy Chang; Ajantha Rhodes; Sharon R Lewin; Paul U Cameron
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

9.  A second subunit of CD8 is expressed in human T cells.

Authors:  A M Norment; D R Littman
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.